During the past decade, Joseph M. Still Research Foundation, Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Joseph M. Still Research Foundation, Inc." #1 sponsor was "Molnlycke Health Care AB" with 2 trials, followed by "3M" with 1 trials sponsored, "Astute Medical, Inc." with 1 trials sponsored, "Avita Medical" with 1 trials sponsored and "Integra LifeSciences Corporation" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Joseph M. Still Research Foundation, Inc." #1 collaborator was "Innovatech Engineering, LLC" with 1 trials as a collaborator, "Joseph M. Still Research Foundation, Inc." with 1 trials as a collaborator and "Registrat-Mapi" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Joseph M. Still Research Foundation, Inc." are "Wound Heal" (3 trials), "Burns" (2 trials), "Acute Kidney Injury" (1 trials), "Bacterial Skin Diseases" (1 trials) and "Catecholamine-resistant Hypotension (CRH)" (1 trials). Many other conditions were trialed in "Joseph M. Still Research Foundation, Inc." in a lesser frequency.

Most popular intervention types in "Joseph M. Still Research Foundation, Inc." are "Device" (6 trials), "Drug" (3 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gel Vehicle" (1 trials), "Invia Motion Endure" (1 trials), "LJPC-501" (1 trials), "Mepilex Ag" (1 trials) and "Mepitel One" (1 trials). Other intervention names were less common.

The vast majority of trials in "Joseph M. Still Research Foundation, Inc." are 13 trials for "All" genders.

Currently, there are NaN active trials in "Joseph M. Still Research Foundation, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Joseph M. Still Research Foundation, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Joseph M. Still Research Foundation, Inc., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".